Sellers finally seem exhausted or out. I think top 20 would account for 60% now - the formal top 20 is not showing this as multiple accounts with one underlying owner.
On a good quarter, deal news or finance, this will fly!
Let us hope that recent additions to the board see this company execute on its true potential. Colinton and Wentworth need this.
Long suffering shareholders need this. No reason this company could not deliver $100m in revenue within 3 years and deliver $40k to the bottom line - $1 share price. I suspect big chemical will strike before then.
Just need a balance of technology and commercial execution. Currently at pivot point and the market is not pricing them for success.
Alexium 2022 - onwards and upwards, page-54
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
